BIOJUVE™ Clinical Study Highlights
The leading edge of natural biological innovation
Key Results
46%
decrease in erythema
49%
decrease in sebum
detected on forehead
53%
decrease in sebum
detected on nose
Methods
A clinical study was performed using XYCM42-based topical regimen, BIOJUVE,
designed to deliver and support the engraftment of live XYCM42 cells onto subjects’ skin.
- 8-week pivotal study
- 121 subjects
- 32 subjects evaluated in-clinic for efficacy baseline, week 1, week 4, and week 8
Study Design
- Subjects were instructed not to use any facial products other than basic facial cleanser and water for cleansing, lipstick, eyeliner and mascara 3 days prior to the start of the study.
- Subjects used the BIOJUVE regimen daily as directed for 8 weeks
- Subjects completed questionnaires at weeks 1, 4, and 8
- Subjects completed daily diaries to track their usage of the products
Continuous improvement over the 8 weeks*
All endpoints measured in the BIOJUVE clinical study showed significant continuous improvement over 8 weeks with results visible in as little as one week. Key results of the study prove that BIOJUVE created significant improvements in the appearance of:
Eight Week Full Face Cosmetic BIOJUVE Clinical Study SUBJECT IMPROVEMENT
Age: 56 | Gender: Female | Fitzpatrick Skin Type: IV
Clinically visible significant improvement in the appearance of:
- texture
- fine lines and coarse wrinkles
- laxity
- sebum production
Age: 57 | Gender: Female | Fitzpatrick Skin Type: I
Clinically visible significant improvement in the appearance of:
- erythema
- photodamage
- fine line and coarse wrinkles
- texture
Age: 66 | Gender: Female | Fitzpatrick Skin Type: II
Clinically visible significant improvement in the appearance of:
- fine lines and coarse wrinkles
- sebum detection
- pore size
- texture
